Innovative Biosensors raises $3.5m
This article was originally published in Clinica
Executive Summary
College Park, Maryland-based Innovative Biosensors has raised $3.5m to be invested in commercialising its pathogen testing technology. The firm, which was established in 2003 with technology licensed from Massachusetts Institute of Technology, has already launched an E coli detection kit and plans to introduce more products for food testing and human clinical diagnostics. The company claims its technology provides rapid results without sacrificing sensitivity. The series A fundraising was led by Harbert Venture Partners. Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005